Drs Vallerie McLaughlin and Oksana Shlobin discuss methods of identifying and navigating challenging clinical scenarios in pulmonary arterial hypertension.

Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/968548). The topics and discussions are planned, produced, and reviewed independently of advertiser. This podcast is intended only for US healthcare professionals.

Resources

What Is Pulmonary Hypertension? https://www.medscape.com/answers/303098-93380/what-is-pulmonary-hypertension

What Are the WHO Clinical Classifications of Pulmonary Hypertension? https://www.medscape.com/answers/303098-93381/what-are-the-who-clinical-classifications-of-pulmonary-hypertension

Interstitial Lung Disease: Pathophysiology and Genetic Predisposition https://www.medscape.com/viewarticle/408750

What Is the Role of Pulmonary Function Testing in the Evaluation of Restrictive Lung Disease? https://www.medscape.com/answers/301760-187987/what-is-the-role-of-pulmonary-function-testing-in-the-evaluation-of-restrictive-lung-disease

What Is the Six-Minute Walk Test (6mwt) in Pulmonary Function Testing? https://www.medscape.com/answers/303239-77869/what-is-the-six-minute-walk-test-6mwt-in-pulmonary-function-testing

Respiratory Failure-V/Q Mismatch https://emedicine.medscape.com/article/167981-overview#a4

Efficacy and Safety of Riociguat in Patients With Symptomatic Pulmonary Hypertension (PH) Associated With Idiopathic Interstitial Pneumonias (IIP) (RISE-IIP) https://clinicaltrials.gov/ct2/show/NCT02138825

Pulmonary Veno-Occlusive Disease https://emedicine.medscape.com/article/1464015-overview

Sodium-Glucose Cotransporter 2 Inhibitors: An Overview https://www.medscape.com/viewarticle/892957_9

Treatment Approach to Connective Tissue Disease-Associated Interstitial Lung Disease https://www.sciencedirect.com/science/article/abs/pii/S1471489222000728